Both in Pharmaceuticals
KALA BIO vs Jupiter Neurosciences
Over the past year KALA returned −99.5% and JUNS returned −97.4%; their daily moves had a correlation of 0.01.
KALA −99.5% JUNS −97.4%Growth of $1, one year, split-adjusted
| Metric | KALA | JUNS |
|---|---|---|
| Price | $0.1781 | $2.46 |
| Market cap | $3.4M | $3.2M |
| Today | +2.95% | +1.23% |
| 1 month | −51.1% | −14.0% |
| 6 months | −96.9% | −91.0% |
| Year to date | −99.4% | −96.8% |
| 1 year | −99.5% | −97.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 86.9% |
| Net margin | — | −9380.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 50.1× |
| Net cash | $7.2M | -$6.6K |
| Dividend yield | — | — |
| Volatility (60d) | 120.4% | 128.2% |
| Short % of float | 3.0% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).